Relative Roles of Targeted Therapies and Immunotherapies in Melanoma

—

by

Cheryl Stratos
in

Anti PD1. Dr. Mario Sznol is Professor of Medicine at the Yale School of Medicine and the clinical Research Program Leader of the Yale Cancer Center’s Melanoma Program. In this interview, Dr. Sznol shares unique insights into these two treatment approaches, including how they compare and how they might be combined

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *